Litcius/Paper detail

Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia

Ari Moskowitz, Matthew S. Shotwell, Kevin W. Gibbs, Michelle Harkins, Yves Rosenberg, James Troendle, Lisa H. Merck, D. Clark Files, Marjolein de Wit, Kristin Hudock, Bruce Thompson, Michelle N. Gong, Adit A. Ginde, David J. Douin, Samuel M. Brown, Eileen Rubin, Meghan M. Joly, Li Wang, Christopher J. Lindsell, Gordon R. Bernard, Matthew W. Semler, Sean P. Collins, Wesley H. Self

2022CHEST Journal23 citationsDOIOpen Access PDF

Topics & Concepts

HypoxemiaMedicineClinical trialIntensive care medicineCoronavirus disease 2019 (COVID-19)Mechanical ventilationInternal medicineDiseaseInfectious disease (medical specialty)Respiratory Support and MechanismsIntensive Care Unit Cognitive DisordersLong-Term Effects of COVID-19
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia | Litcius